These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31342066)

  • 1. Ibrexafungerp: A novel oral glucan synthase inhibitor.
    Davis MR; Donnelley MA; Thompson GR
    Med Mycol; 2020 Jul; 58(5):579-592. PubMed ID: 31342066
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Nunnally NS; Etienne KA; Angulo D; Lockhart SR; Berkow EL
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.
    Pfaller MA; Messer SA; Rhomberg PR; Borroto-Esoda K; Castanheira M
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor.
    Apgar JM; Wilkening RR; Parker DL; Meng D; Wildonger KJ; Sperbeck D; Greenlee ML; Balkovec JM; Flattery AM; Abruzzo GK; Galgoci AM; Giacobbe RA; Gill CJ; Hsu MJ; Liberator P; Misura AS; Motyl M; Nielsen Kahn J; Powles M; Racine F; Dragovic J; Fan W; Kirwan R; Lee S; Liu H; Mamai A; Nelson K; Peel M
    Bioorg Med Chem Lett; 2021 Jan; 32():127661. PubMed ID: 33160023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis.
    Azie N; Angulo D; Dehn B; Sobel JD
    Expert Opin Investig Drugs; 2020 Sep; 29(9):893-900. PubMed ID: 32746636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida Species and Aspergillus species isolates.
    Jiménez-Ortigosa C; Paderu P; Motyl MR; Perlin DS
    Antimicrob Agents Chemother; 2014; 58(2):1248-51. PubMed ID: 24323472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives on echinocandin class drugs.
    Perlin DS
    Future Microbiol; 2011 Apr; 6(4):441-57. PubMed ID: 21526945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
    Spec A; Pullman J; Thompson GR; Powderly WG; Tobin EH; Vazquez J; Wring SA; Angulo D; Helou S; Pappas PG;
    J Antimicrob Chemother; 2019 Oct; 74(10):3056-3062. PubMed ID: 31304536
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Bouza E; Guinea J
    J Antimicrob Chemother; 2017 Jul; 72(7):1969-1976. PubMed ID: 28175309
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.
    Lamoth F; Alexander BD
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4308-11. PubMed ID: 25896696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
    Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Pharmacokinetics and Drug-Drug Interaction Potential for Coadministered SCY-078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus.
    Wring S; Murphy G; Atiee G; Corr C; Hyman M; Willett M; Angulo D
    Clin Pharmacol Drug Dev; 2019 Jan; 8(1):60-69. PubMed ID: 29947477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.
    Hori Y; Shibuya K
    Med Mycol J; 2018; 59(2):E31-E40. PubMed ID: 29848909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis.
    Ghannoum M; Long L; Larkin EL; Isham N; Sherif R; Borroto-Esoda K; Barat S; Angulo D
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R; Khachikian D; Reboli AC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species.
    Schell WA; Jones AM; Borroto-Esoda K; Alexander BD
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis.
    Larkin EL; Long L; Isham N; Borroto-Esoda K; Barat S; Angulo D; Wring S; Ghannoum M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30885896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against
    Gamal A; Chu S; McCormick TS; Borroto-Esoda K; Angulo D; Ghannoum MA
    Front Cell Infect Microbiol; 2021; 11():642358. PubMed ID: 33791244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.